INTERNATIONAL PATENT: BIONTECH SE FILES APPLICATION FOR "INTERLEUKIN 18 RECEPTOR AGENTS FOR SPECIFIC ACTIVATION OF IMMUNE EFFECTOR CELLS"

GENEVA, Oct. 13 -- BIONTECH SE (An der Goldgrube 1255131 Mainz) filed a patent application (PCT/EP2025/056797) for "INTERLEUKIN 18 RECEPTOR AGENTS FOR SPECIFIC ACTIVATION OF IMMUNE EFFECTOR CELLS" on Mar 12, 2025. With publication no. WO/2025/209797, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAHIN, Ugur (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), FRANK, Annika (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), VELASCO CARDENAS, Rubi Misol Ha (c/o BioNTech SEAn der Goldgrube 1255131 Mainz), LILL, Julia (c/o BioNTe...